Kornej J, Dinov B, Blann AD, Rolf S, Arya A, Schmidl J, Husser D, Hindricks G, Bollmann A, Lip GY. Effects of radiofrequency catheter ablation of atrial fibrillation on soluble p-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation. PLoS One. 2014 Nov 12;9(11):e111760.
2.
Koutalas E, Bertagnolli L, Sommer P, Richter S, Rolf S, Breithardt O, Bollmann A, Hindricks G, Arya A. Efficacy and safety of remote magnetic catheter navigation vs. manual steerable sheath-guided ablation for catheter ablation of atrial fibrillation: a case-control study. Europace. 2014 Oct 21. [Epub ahead of print]
3.
Kornej J, Hindricks G, Banerjee A, Arya A, Sommer P, Rolf S, Husser D, Lip GY, Bollmann A. Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences. Heart. 2014 Oct 3. [Epub ahead of print]
4.
Dinov B, Arya A, Bertagnolli L, Schirripa V, Schoene K, Sommer P, Bollmann A, Rolf S, Hindricks G. Early Referral for Ablation of Scar-Related Ventricular Tachycardia Is Associated with Improved Acute and Long Term Outcomes: Results from the Heart Center of Leipzig Ventricular Tachycardia Registry. Circ Arrhythm Electrophysiol. 2014 Sep 27. [Epub ahead of print]
5.
Kosiuk J, Koutalas E, Doering M, Nedios S, Sommer P, Rolf S, Darma A, Breithardt OA, Dinov B, Hindricks G, Richter S, Bollmann A. Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Circ J. 2014 Sep 25;78(10):2402-7.
6.
Döring M, Sommer P, Rolf S, Lucas J, Breithardt OA, Hindricks G, Richter S. Sensor-Based Electromagnetic Navigation to Facilitate Implantation of Left Ventricular Leads in Cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol. 2014 Sep 17. [Epub ahead of print]
7.
Kosiuk J, Koutalas E, Doering M, Nedios S, Sommer P, Rolf S, Darma A, Breithardt OA, Dinov B, Hindricks G, Richter S, Bollmann A. Comparison of Dabigatran and Uninterrupted Warfarin in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Implantations. Circ J. 2014 Aug 22. [Epub ahead of print]
8.
Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, Gaspar T, Bollmann A, Altmann D, Piedra C, Hindricks G, Piorkowski C. Tailored Atrial Substrate Modification Based On Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2014 Oct;7(5):825-33.
9.
Nedios S, Kornej J, Koutalas E, Bertagnolli L, Kosiuk J, Rolf S, Arya A, Sommer P, Husser D, Hindricks G, Bollmann A. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation. Heart Rhythm. 2014 Aug 14. [Epub ahead of print]
10.
Nedios S, Kornej J, Koutalas E, Bertagnolli L, Kosiuk J, Rolf S, Arya A, Sommer P, Husser D, Hindricks G, Bollmann A. Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation. Heart Rhythm. 2014 Aug 14. [Epub ahead of print]
11.
Dagres N, Rolf S, Hindricks G. Percutaneous left atrial appendage suture ligation: not ready for prime time. J Am Coll Cardiol. 2014 Aug 12;64(6):573-5.
12.
Kosiuk J, Kornej J, Bollmann A, Piorkowski C, Myrda K, Arya A, Sommer P, Richter S, Rolf S, Husser D, Gaspar T, Lip GY, Hindricks G. Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors. Heart Rhythm. 2014 Jul 30. [Epub ahead of print]
13.
Bode K, Rolf S, Sommer P, Richter S, Hindricks G. [Long-term results of catheter ablation of atrial fibrillation : Cure or just palliation?]. Herzschrittmacherther Elektrophysiol. 2014 Aug 1. [Epub ahead of print]
14.
Sommer P, Rolf S, Piorkowski C, Gaspar T, Huo Y, Piedra C, Richter S, Bollmann A, Arya A, Hindricks G. Non-Fluoroscopic Catheter Visualization in AF Ablation: Experience from 375 Consecutive Procedures. Circ Arrhythm Electrophysiol. 2014 Oct;7(5):869-74.
15.
Kosiuk J, Nedios S, Kornej J, Koutalas E, Bertagnolli L, Rolf S, Arya A, Sommer P, Husser D, Hindricks G, Bollmann A. Impact of left atrial appendage morphology on peri-interventional thromboembolic risk during catheter ablation of atrial fibrillation. Heart Rhythm. 2014 Sep;11(9):1522-7.
16.
Kosiuk J, Nedios S, Kornej J, Koutalas E, Bertagnolli L, Rolf S, Arya A, Sommer P, Husser D, Hindricks G, Bollmann A. Impact of Left Atrial Appendage Morphology on Peri-interventional Thromboembolic Risk during Catheter Ablation of Atrial Fibrillation. Heart Rhythm. 2014 May 22. pii: S1547-5271(14)00553-0. doi: 10.1016/j.hrthm.2014.05.022. [Epub ahead of print]
17.
Dinov B, Kosiuk J, Kircher S, Bollmann A, Acou WJ, Arya A, Hindricks G, Rolf S. Impact of Metabolic Syndrome on Left Atrial Electro-Anatomical Remodeling and Outcomes after Radiofrequency Ablation of Non Valvular Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2014 May 15. pii: CIRCEP.113.001185. [Epub ahead of print]
18.
Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7.
19.
Huo Y, Schoenbauer R, Richter S, Rolf S, Sommer P, Arya A, Rastan A, Doll N, Mohr FW, Hindricks G, Piorkowski C, Gaspar T. Atrial Arrhythmias Following Surgical AF Ablation: Electrophysiological Findings, Ablation Strategies, and Clinical Outcome. J Cardiovasc Electrophysiol. 2014 Mar 6. doi: 10.1111/jce.12406. [Epub ahead of print]
20.
Efimova E, Riahi S, Fiedler L, Esato M, Sommer P, Richter S, Breithardt O, Rolf S, Bollmann A, Hindricks G, Arya A. Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast atrioventricular nodal reentrant tachycardia: a prospective study. Heart Rhythm. 2014 May;11(5):871-6.
21.
Kosiuk J, Nedios S, Darma A, Rolf S, Richter S, Arya A, Piorkowski C, Gaspar T, Sommer P, Husser D, Hindricks G, Bollmann A. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. Europace. 2014 Feb 13. [Epub ahead of print]
22.
Kosiuk J, Koutalas E, Doering M, Sommer P, Rolf S, Breithardt OA, Nedios S, Dinov B, Hindricks G, Richter S, Bollmann A. Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations. Europace. 2014 Jan 31. [Epub ahead of print]
23.
Sommer P, Richter S, Hindricks G, Rolf S. Non-fluoroscopic catheter visualization using MediGuideâ„¢ technology: experience from the first 600 procedures. J Interv Card Electrophysiol. 2014 Jan 16. [Epub ahead of print]
24.
Nedios S, Sommer P, Gaspar T, Arya A, Bollmann A, Richter S, Kanagkinis N, Hindricks G, Piorkowski C, Rolf S. Long-term course after atrial fibrillation ablation in patients with impaired left ventricular systolic function. The importance of sinus rhythm maintenance. Heart Rhythm. 2014 Mar;11(3):344-51
25.
Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, Hindricks G, Arya A. Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Non-Ischemic Cardiomyopathy in Comparison to Ischemic Cardiomyopathy: Results from the Prospective HEart Centre of LeiPzig VT (HELP - VT) Study. Circulation. 2014 Feb 18;129(7):728-36.
26.
Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A. Renal Dysfunction, Stroke Risk Scores (CHADS2, CHA2DS2-VASc and R2CHADS2) and the Risk of Thromboembolic Events after Catheter Ablation of Atrial Fibrillation: The Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol. 2013 Sep 18. [Epub ahead of print]
27.
Richter S, Döring M, Gaspar T, John S, Rolf S, Sommer P, Hindricks G, Piorkowski C. CRT Implantation Using a New Sensor-Based Navigation System:Results from the First Human Use Study. Circ Arrhythm Electrophysiol. 2013 Oct;6(5):917-23.
28.
Eitel C, Rolf S*, Zachaeus M, John S, Sommer P, Bollmann A, Piorkowski C, Hindricks G, Halm U. Successful Non-Surgical Treatment of Esophagopericardial Fistulas following Atrial Fibrillation Catheter Ablation - a Case Series. Circ Arrhythm Electrophysiol2013 Aug 1;6(4):675-81.
29.
Kosiuk J, Buchta P, Gaspar T, Arya A, Piorkowski C, Rolf S, Sommer P, Husser D, Hindricks G, Bollmann A. Prevalence and predictors of worsened left ventricular diastolic dysfunction after catheter ablation of atrial fibrillation. Int J Cardiol. 2013 May 30. [Epub ahead of print]
30.
Rolf S, Sommer P, John S, Kircher S, Gaspar T, Arya A, Piorkowski C, Hindricks G. Catheter ablation of atrial fibrillation supported by non-fluoroscopic 4D catheter tracking. Heart Rhythm. 2013 Sep;10(9):1293-300.
31.
Parwani AS, Boldt LH, Huemer M, Wutzler A, Blaschke D, Rolf S, Möckel M, Haverkamp W. Atrial fibrillation-induced cardiac troponin I release. Int J Cardiol. 2013 Apr 23. [Epub ahead of print]
32.
Sommer P, Gaspar T, Eitel C, Derndorfer M, Martinek M, Puererfellner H, Arya A, Piorkowski C, Hindricks G, Rolf S. MediGuide in SVT: initial experience from a multicenter registry. Europace. 2013 Sep;15(9):1292-7.
33.
Gaspar T, Sih H, Hindricks G, Eitel C, Sommer P, Kircher S, Rolf S, Arya A, Teplitsky L, Piorkowski C. Use of electrical coupling information in AF catheter ablation: A prospective randomized pilot study. Heart Rhythm. 2013 Feb;10(2):176-81.
34.
Sommer P, Rolf S, Richter S, Hindricks G, Piorkowski C. Nicht fluoroskopische Katheternavigation: das MediGuideâ„¢-System. Herzschrittmacherther Elektrophysiol. 2012 Nov 21.
35.
Huo Y, Braunschweig F, Gaspar T, Richter S, Schönbauer R, Sommer P, Arya A, Rolf S, Bollmann A, Hindricks G, Piorkowski C. Diagnosis of atrial tachycardias originating from the lower right atrium: importance of P-wave morphology in the precordial leads V3-V6. Europace. 2012 Oct 10. [Epub ahead of print]
36.
Sommer P, Wojdyla-Hordynska A, Rolf S, Gaspar T, Eitel C, Arya A, Hindricks G, Piorkowski C. Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system. Europace. 2012 Aug 2. [Epub ahead of print]
37.
Gaspar T, Kircher S, Arya A, Sommer P, Rolf S, Hindricks G, Piorkowski C. Enhancement of intracardiac navigation by new GPS-guided location system (MediGuide Technologies). Europace. 2012 Aug;14 Suppl 2:ii24-ii25.
38.
Rolf S, Sommer P, John S, Gaspar T, Arya A, Hindricks G, Piorkowski C. Ablation of atrial fibrillation using novel 4D catheter tracking within auto-registered LA angiograms. Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):684-90.
39.
Kiuchi K, Kircher S, Watanabe N, Gaspar T, Rolf S, Arya A, Piorkowski C, Hindricks G, Sommer P. Quantitative Analysis of Isolation Area and Rhythm Outcome in Patients With Paroxysmal Atrial Fibrillation After Circumferential Pulmonary Vein Antrum Isolation Using the Pace-and-Ablate Technique. Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):667-75.
40.
Kosiuk J, Van Belle Y, Bode K, Kornej J, Arya A, Rolf S, Husser D, Hindricks G, Bollmann A. Left Ventricular Diastolic Dysfunction in Atrial Fibrillation: Predictors and Relation with Symptom Severity. J Cardiovasc Electrophysiol. 2012 Oct;23(10):1073-7.
41.
Sommer P, Rolf S, Gaspar T, Piorkowski C, Hindricks G. Non-fluoroscopic Catheter Tracking for Interventional Electrophysiology Procedures: The MediGuide System. J Innov Card Rhythm Management. 2012 Sep;(3)922-929.
42.
Dinov B, Schönbauer R, Wojdyla-Hordynska A, Braunschweig F, Richter S, Altmann D, Sommer P, Gaspar T, Bollmann A, Wetzel U, Rolf S, Piorkowski C, Hindricks G, Arya A. Long-term efficacy of single procedure remote magnetic catheter navigation for ablation of ischemic ventricular tachycardia: a retrospective study. J Cardiovasc Electrophysiol. 2012 May;23(5):499-505.
43.
Eckardt L, Rolf S, Möönnig G, Bruns HJ, Schulze-Bahr E, Milberg P, Kirchhof P, Wichter T, Borggrefe M, Breithardt G, Haverkamp W. Klinik und Therapie des Brugada-Syndroms. Herzschrittmachertherapie & Elektrophysiologie 04/2012; 13(3):157-165.
44.
Huemer M, Boldt LH, Wutzler A, Parwani A, Rolf S, Blaschke D, Haverkamp W. Polymorphic ventricular tachycardia in a patient with herpes encephalitis. J Clin Neurosci. 2012 Mar;19(3):483-4.
45.
Wutzler A, Rolf S*, Huemer M, Parwani AS, Boldt LH, Herberger E, Hohenbichler K, Dietz R, Haverkamp W. Safety aspects of deep sedation during catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012 Jan;35(1):38-43.
46.
Rolf S, Boldt LH, Parwani AS, Wutzler A, Huemer M, Blaschke D, Herberger E, Haverkamp W. Findings and outcome of fluoroscopic visualization of the oesophageal course during catheter ablation of atrial fibrillation. Europace. 2011 Jun;13(6):796-802.
47.
Piorkowski C, Eitel C, Rolf S, Bode K, Sommer P, Gaspar T, Kircher S, Wetzel U, Parwani AS, Boldt LH, Mende M, Bollmann A, Husser D, Dagres N, Esato M, Arya A, Haverkamp W, Hindricks G. Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol. 2011;4:157-165.
48.
Rolf S, Gaspar T, Sommer P, Kircher S, Arya A, Wetzel U, Bollmann A, Hindricks G, Piorkowski C. Katheterablation von Vorhofflimmern - Neue Technologien und Strategien. Austrian J Cardiol 2011 (3-4): 76-80.
49.
Rolf S, Motz W, Horstkotte D. Epidemiologie des Vorhofflimmerns. Klinikarzt 2011 (40): 7-12.
50.
Boldt LH, Posch MG, Perrot A, Polotzki M, Rolf S, Parwani AS, Huemer M, Wutzler A, Ozcelik C, Haverkamp W. Mutational analysis of the PITX2 and NKX2-5 genes in patients with idiopathic atrial fibrillation. Int J Cardiol. 2010 Nov 19;145(2):316-7.
51.
Posch MG, Boldt LH, Polotzki M, Richter S, Rolf S, Perrot A, Dietz R, Ozcelik C, Haverkamp W. Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet. 2010 Jul-Aug;53(4):201-3.
52.
Rolf S, Haverkamp W. [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?]. Herz. 2009 Nov;34(7):528-38.
53.
53. Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis. Europace. 2009 Mar;11(3):289-96.
54.
Blaschke D, Rolf S, Parwani AS, Huemer M, Dietz R, Garbe E, Haverkamp W. [Drug-induced valvular heart disease]. Dtsch Med Wochenschr. 2009 Feb;134(8):365-70.
55.
Parwani AS, Rolf S, Haverkamp W. Coronary artery occlusion due to lead insertion into the right ventricular outflow tract. Eur Heart J. 2009 Feb;30(4):425.
56.
Huemer M, Boldt LH, Rolf S, Blaschke D, Parwani A, Haverkamp W. Sustained monomorphic ventricular tachycardia after adenosine infusion. Int J Cardiol. 2009 Jan 24;131(3):e97-100.
57.
Boldt LH, Rolf S, Dietz R, Haverkamp W. [Atrial fibrillation in patients with heart failure. [Pathophysiological concepts and therapeutic options]. Dtsch Med Wochenschr. 2008 Nov;133(45):2349-54.
58.
Boldt LH, Rolf S*, Huemer M, Parwani AS, Luft FC, Dietz R, Haverkamp W. Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation. Am Heart J. 2008 May;155(5):890-5.
59.
Blaschke D, Parwani AS, Huemer M, Rolf S, Boldt LH, Dietz R, Haverkamp W. Torsade de pointes during combined treatment with risperidone and citalopram. Pharmacopsychiatry. 2007 Nov;40(6):294-5.
60.
Rolf S, Holzmeister J, Fruehwirth M, Haverkamp W. Idiopathic left ventricular tachycardia: procedural and fluoroscopy time saving ablation using LocaLisa navigation system. J Cardiovasc Electrophysiol. 2006 Feb;17(2):214-5.
61.
Haverkamp W, Rolf S, Osterziel KJ, Dietz R, Peters S. [Arrhythmogenic right ventricular cardiomyopathy]. Herz. 2005 Sep;30(6):565-70.
62.
Haverkamp W, Rolf S, Stockburger M, Dietz R. [Acute treatment of stable hemodynamically tolerable ventricular tachycardia]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Apr;40(4):207-12.
63.
Haverkamp W, Rolf S, Eckardt L, Mönnig G. [Long QT syndrome and Brugada Syndrome. Drugs, ablation or ICD?]. Herz. 2005 Mar;30(2):111-8.
64.
Rolf S, Haverkamp W, Eckardt L. True right bundle branch block masking the typical ECG in Brugada syndrome. Pacing Clin Electrophysiol. 2005 Mar;28(3):258-9.
65.
Haverkamp W, Dietz R, Rolf S. Vorhofflimmern-Rezidive während Langzeitbehandlung mit Amiodaron: Versagen der Therapie oder unzureichende Dosierung? Austrian J Cardiol 2004; 11 (Suppl): 11-12.
66.
Kirchhof P, Eckardt L, Rolf S, Esperer HD, Paul M, Wichter T et al. T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome. Ann Noninvasive Electrocardiol 2004;9(2):162-165.
67.
Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K et al. The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol. Eur Heart J 2003;24(12):1104-1112.
68.
Eckardt L, Kirchhof P, Schulze-Bahr E, Rolf S, Ribbing M, Loh P et al. Electrophysiologic investigation in Brugada syndrome - Yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. Eur Heart J 2002;23(17):1394-1401.
69.
Kirchhof P, Loh P, Eckardt L, Ribbing M, Rolf S, Eick O et al. A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias. Am J Cardiol 2002;90(3):340-3.
70.
Rolf S, Haverkamp W, Borggrefe M, Musshoff U, Eckardt L, Mergenthaler J et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn-Schmiedebergs PharmacologyArch Pharmacol 2000;362(1):22-31.
Buchartikel
1.
Rolf S, Möckel M (Für die deutsche Ausgabe) Loscalzo J. Palpitationen. In: Dietel M, Suttorp N, Zeitz M. Deutsche Ausgabe Harrisons Innere Medizin, 18. Auflage. ABW Wissenschaftsverlag, Berlin, 20012:317-318.
2.
Rolf S, Möckel M (Für die deutsche Ausgabe) Spragg D. Grundlagen der Elektrophysiologie. In: Dietel M, Suttorp N, Zeitz M. Deutsche Ausgabe Harrisons Innere Medizin, 18. Auflage. ABW Wissenschaftsverlag, Berlin, 20012:317-318.
3.
Haverkamp W, Kühnle Y, Rolf S. Gefäßzugänge: Allgemeine Prinzipien und Methoden. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:134-140.
4.
Rolf S. Mechanische und elektrische Therapie kardialer Arrhythmien, Anlage eines temporären Schrittmachers. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:181-194.
5.
Rolf S. Herz-Kreislauf: Messung des zentralen Venendrucks (ZVD), ZVD-Kurve. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:230-232.
6.
Rolf S. Herz-Kreislauf: EKG-Spezialableitungen. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:225-228.
7.
Rolf S. Herz-Kreislauf: Physiologie und Pathophysiologie. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:210-220.
8.
Rolf S. Herz-Kreislauf: Aufnahmecheckliste (Untersuchungsmethoden und Diagnostik). In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:220-225.
9.
Rolf S. Herz-Kreislauf: Pulmonalarterienkatheter. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:232-238.
10.
Rolf S. Herz-Kreislauf: PiCCO. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:238-240.
Rolf S. Herz-Kreislauf: Notfälle bei Patienten mit Herzschrittmacher und ICD. In: Haverkamp W, Herth FJF, Messmann H. Internistische Intensivmedizin. Thieme, Stuttgart, 2008:282-286.
13.
Rolf S, Dietz R (Für die deutsche Ausgabe) Loscalzo J. Palpitationen. In: Dietel M, Suttorp N, Zeitz M. Deutsche Ausgabe Harrisons Innere Medizin, 17 Auflage. ABW Wissenschaftsverlag, Berlin, 2008:298-299.